Subsequent Events

On November 24, 2015, our board of directors approved a forward stock split of our authorized and issued and outstanding shares of common stock on a basis of 1 old share of common stock for 1.1 new shares of common stock. Upon effect of the forward stock split our authorized capital increased to 220,000,000 shares of common stock, par value $0.001 and our issued and outstanding shares increased from 39,952,984 to 43,948,286 shares of common stock, with a par value of $0.001. The reverse stock split has been reviewed by the Financial Industry Regulatory Authority ("FINRA") and the Canadian Securities Exchange ("CSE") and was approved for filing with an effective date of December 16, 2015. The forward split became effective with the OTC Markets at the opening of trading on December 16, 205 under the symbol "LXRPD". The "D" will be placed on our ticker symbol for 20 business days. Our new CUSIP number is 52886N307.

On December 10, 2015, Lexaria closed a private placement by issuing 500,000 units at a price of US$0.18 per unit for gross proceeds of US$90,000. Each Unit consists of one common share of the Company and one half transferable Share purchase warrant ("Warrant"). Each Full Warrant will be exercisable into one further Share (a "Warrant Share") at a price of US$0.30 per Warrant Share for a period of twenty four (24) months following closing. A cash finders( fee for $2,520 was paid to Leede Financial Markets Ltd.; and 14,000 broker warrants with an exercise price of $0.30 for a period of twenty four months were issued to Leede Financial Markets Ltd.

On December 14, 2015 , Lexaria signed an Investor Relations contract with Radius Consulting Inc. for a 45 day term. Radius will receive $2,500 and 50,000 restricted common shares at a price of $0.20 per share.